... As Avecia Enters The Field | Chemical & Engineering News
Volume 85 Issue 21 | p. 16 | Concentrates
Issue Date: May 21, 2007

... As Avecia Enters The Field

Department: Business

Meanwhile, Avecia has launched a new microbial protein production platform called pAVEway. Mark Carver, chief scientific officer at Avecia Biologics, says the platform can use Eschericia coli, the most widely used microbial expression host, and Pseudomonas. Avecia joins Dowpharma as well as DSM, which has a licensing joint venture with Crucell for human cell-based protein and monoclonal antibody production, as a supplier of protein expression technologies.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment